|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: d9: complainant part is not expected to be returned for manufacturer review/investigation.H3, h6: the investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.H4: part #: (b)(6).Lot #: 6639p72.Manufacturing site: jabil bettlach.Release to warehouse date: 11, july 2023.Expiry date: 30, june 2033.A manufacturing record evaluation was performed for the finished device lot and no non-conformance was identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
It was reported that on july 27, 2023 the surgeon commented that the nail had medialized so much as it was hugging the medial cortex distally.There was no direct allegations against the nail, it was more about position.There was no surgical delay.The surgery was successfully completed.There was no patient consequences.This report is for one (1) 10 / ti cann frn / pf 380 / right - sile.This is report 1 of 1 for complaint (b)(4).
|